Incremental Value of Cystatin C Over Conventional Renal Metrics for Predicting Clinical Response and Outcomes in Cardiac Resynchronization Therapy: The BIOCRT Study

BACKGROUND: Despite the benefit of CRT in select patients with heart failure (HF), there remains significant need for predicting those at risk for adverse outcomes for this effective but costly therapy. CysC, an emerging marker of renal function, is predictive of worsening symptoms and mortality in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Cardiol
Huvudupphovsmän: Chatterjee, Neal A., Singh, Jagmeet P., Szymonifka, Jackie, Deaño, Roderick C., Thai, Wai-ee, Wai, Bryan, Min, James K., Januzzi, James L., Truong, Quynh A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718799/
https://ncbi.nlm.nih.gov/pubmed/26710332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcard.2015.12.002
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk